The biosimilars market is undergoing rapid change with developments such as the recent approvals of infliximab and trastuzumab heralding a new era. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of biosimilars, but there is still a lack of consistency, particularly between the two leading agencies – the FDA and EMA. Moreover, there are some concerns around biosimilar use, for example with physicians worried about how similar certain drugs are and whether they can safely be used in particular patient populations such as transplant, due to the potential for variance in efficacy and tolerability.
Subscription to this product provides access during one year to three Competitive Intelligence information products released by La Merie Publishing with great cost savings: 1) Flat-Rate Access to La Merie Publishing Reports: Access during one year to all existing and new reports produced by La Merie Publishing and listed in the online store. Among La Merie Publishing reports are Competitor Analysis reports as well as Full Reports. La Merie Publishing reports are continuously updated and new ones released.
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets: Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) G-CSF & GM-CSF Thrombopoietin & Thrombopoiesis Stimulating Agents Interferon Insulin Coagulation Factors
Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016, growing at a CAGR of 9.2% for the analysis period 2012-2018 respectively. North American region accounts for highest percentage approximately 35.8% (2015) of global share while Europe follows next with nearly 28.8% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.6% driving a market value of US$4.7 billion by 2015.
Anaesthetic Gas Monitor Sales Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Waterproof Band-Aid Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
In this report, the global Pharmaceutical Cold chain Logistics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Global Next Generation Sequencing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Next Generation Sequencing industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
The report provides a basic overview of the industry including definitions and classifications. The Clinical Decision Support System market analysis is provided for the USA markets including development trends, competitive landscape analysis, and key regions development status.
2016 Global Biostimulants Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biostimulants industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).
2016 Global Biotherapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biotherapeutics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).
In this report, the global Biologic Response Modifier market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
In this report, the global Bactericides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
In this report, the United States Activated PEGs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This new market research report forecasts on Pharmaceutical Cold chain Logistics Market providing complete market figures, consisting market size and estimation by Pharmaceutical Cold chain Logistics Market application and products depending upon geographical location for the forecasting period 2017 to 2025.
This new market research report forecasts on Biologic Response Modifier Market providing complete market figures, consisting market size and estimation by Biologic Response Modifier Market application and products depending upon geographical location for the forecasting period 2017 to 2025.
Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. This technique allows the organs to be grown from implantation and hence is free from immunological rejection.
Prebiotics are the non- digestible functional ingredients that selectively stimulate the growth of favorable bacteria’s in the gut of the host. Prebiotics facilitate the immune system thereby improving animal health.The market for prebiotics in animal feed is growing on the back of rising meat consumption. Meat and its products is considered as one of the major source of proteins, vitamins and mineralswhich are essential for growth and development.
The Global Single-use Bio-processing Systems market is expected to witness significant growth during the forecast period primarily by the growing demand and cost- effective features of these single-use systems, which are mostly used in R&D applications. The essential bio-processing systems used in R&D applications are disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and probes/sensors.
The purpose of this strategic research study titled “Cell Culture Media and Reagents Market- Growth, Future Prospects and Competitive Analysis, 2016 – 2023” is to offer industry investors, company executives, and industry participants with indepth insights to enable them make informed strategic decisions related to the opportunities in the cell culture media and reagents market.
Uniform and quality yield is of utmost importance among micronutrients product manufacturers, agrochemical manufacturers and other key participants in the agriculture industry. Agricultural micronutrients are plant nutrients, which are used in small amounts for obtaining better yield.
Inulin is a term used to describe a group of polysaccharides that is produced by numerous plants. It is a type of dietary fiber which is usually found in the roots of plants. Herb chicory is a plant from which most of the inulin is extracted. As a natural fiber, inulin provides a number of important health benefits, such as helps in preventing constipation, lowers cholesterol levels, and promotes good bacteria (probiotics) in the intestinal tract.
Pharmacogenomics refers to the study of the human genetic make-up and corresponding tailoring of the drug treatment. Each individual response to the drug varies according to the genetic composition. To address such variations, it is necessary to study how the drug processing is affected by the genes. Precise genetic testing helps in determining targeted drug therapies and streamline the treatment protocol to improve therapeutic results.
Animal feed enzymes helps to increase the nutrition proportion in animal foodstuff and also lower the amount of animal waste. Increasing consumer awareness regarding the meat quality and various dairy products, along with the rising consumption of meat has led to inclusion of feed additives into animal feed. The poultry segment is likely to lead the market in forecast period.
The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma.
Global Stem Cells Market by Products (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells and Very Small Embryonic Like Stem Cells) by Applications (Regenerative Medicine, Drug Discovery and Development) by Therapy (Autologous Stem Cells Therapy, Allogenic Stem Cells Therapy) - Market Growth, Future Prospects & Competitive Analysis, 2017 – 2025
The biological safety testing market is set to reach US$ 8,935.4 Mn by 2026 from US$ 3,120.8 Mn in 2017 growing at an impressive pace with a compounded annual growth rate (CAGR) of 12.5% during the forecast period from 2018 to 2026. The primary features responsible for the biological safety testing market are rising prevalence of chronic diseases and rapid growth in the clinical laboratories worldwide.
Biometrics in healthcare applications essentially refer to staff and patient identification solutions. Biometrics solutions are often used in combination with smart cards and passwords for secure access to sensitive records and reports, and to facilitate patient registration requirements. In the near future biometrics use in healthcare will reflect the growing demand to address healthcare frauds in the developed markets along with the escalating need to ensure patient privacy.
Cell cultures are an important and fundamental tool essential for the development of target based therapies such as biosimilars, biologics and personalized medicine. The current trend for developing medication is making it more patient centric thus personalized medicines are in greater demand for treating various chronic conditions and orphan indications. The development of target based therapies for the above-mentioned conditions require to be carried at a faster pace with no scope for errors during the development stages.
Cell isolation & separation is the process of separating individual living cells from another within a biological sample such as blood or tissue. Cell isolation & separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration.
Immunization of livestock has been carried out worldwide for centuries and is also accepted as a cost effective measure of controlling infections. Until recently, vaccines were either live attenuated or inactivated organisms formulated with oil-based adjuvant; however these methods and formulations were not very effective.
Phospholipase enzyme market is projected to reach US$ 482.4 Mn by 2026 with 7.0% CAGR during the forecast period from 2018 to 2026. In 2017, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest growing region between 2018 and 2026.
The antimicrobial susceptibility test market had market size of 2,755.9 Mn in 2017 and will grow at a CAGR 4.7% and is anticipated to reach 4,159.2 Mn in 2026. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics.
The bone marrow transplantation market is set to reach from US$ 8,356.4 Mn in 2017 to US$ 13,903.1 Mn by 2026 highlighting straightforward growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. According to the research findings provided by Bristol-Myers Squibb Company, by 2040 there will be 1.85 million new cases of blood cancer will be reported worldwide.
Biopharmaceutical Market Research Reports
Biopharmaceutical is termed as a drug that is manufactured by biotechnological means. It is a therapeutic agent aimed at treating various kinds of disease symptoms, diseases and disorders of the body. Biopharmaceutical is a drug not produced due to any chemical reaction nor through any synthesized biological source. But it is produced through use of living organisms like bacteria, yeast, stem cells or mammalian cells which may have been altered to generate the required compound. Biopharmaceutical is available in the form of RNA protein, DNA protein and nucleic acid in nature. It is used for healing purpose and in vivo diagnostic process.
The initial biopharmaceutical drug introduced for therapeutic use in the medical field was artificial human insulin. This drug was released in year 1982 to utilize it in treatment of diabetic patients all over the globe.
Biopharmaceutical drug has been effective in treating the most inflexible medical conditions like cancer ailment and autoimmune disease. It is manufactured by using certain distinctive method whose research cost and cost of production is very high. Due to this, these drug is placed among the high cost lists of drug prescriptions.
As per the biotechnology market, over four hundred biopharmaceutical items are used in treatment of two hundred ailments in medical experimental phases, some of whom for which no medical treatment is available till date. Since last few years, Food and Drug Administration (FDA), a regulatory body based in USA which regulates the use of drugs all over the world, has approved biopharmaceutical items for treating different kinds of medical ailments arising due to various medical conditions. As a result, the export flow of the biopharmaceutical drugs has almost doubled from a figure of thirty five billion US dollars to seventy three billion US dollars. Today, the biopharmaceutical market is flourishing in terms of market revenue, exploration, advances, benefits, advantages, biotechnological breakthroughs and medical as well as scientific achievements.
You can search for the related information about the biopharmaceuticals drugs and products on our web portal displaying biopharmaceutical market research reports.
